The involvement of Notch signaling in melanoma vasculogenic mimicry (Q39342547)

11 September 2017

The involvement of Notch signaling in melanoma vasculogenic mimicry (English)

1 reference

11 September 2017

1 reference

Amalia Vartanian

1

1 reference

11 September 2017

Galina Gatsina

2

1 reference

11 September 2017

Irina Grigorieva

3

1 reference

11 September 2017

Elico Solomko

4

1 reference

11 September 2017

Vladislav Dombrovsky

5

1 reference

11 September 2017

Anatoly Baryshnikov

6

1 reference

11 September 2017

Eugenia Stepanova

7

1 reference

11 September 2017

25 May 2012

1 reference

Clinical and Experimental Medicine

11 September 2017

1 reference

11 September 2017

13

1 reference

11 September 2017

3

1 reference

11 September 2017

201-209

1 reference

https://scigraph.springernature.com/pub.10.1007/s10238-012-0190-9

11 September 2017

0 references

cites work

Vasculogenensis, angiogenesis and special features of tumor blood vessels

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

Do not say ever never more: the ins and outs of antiangiogenic therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

VEGF/VEGFR pathway inhibitors as anti-angiogenic agents: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

Molecular predictors of response to antiangiogenesis therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

The Notch signaling pathway: molecular basis of cell context dependency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

Dynamics of endothelial cell behavior in sprouting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

Notch signaling in the regulation of stem cell self-renewal and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

Possible novel targets for therapeutic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

Cancer/testis genes expression in human melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

The involvement of apoptosis in melanoma vasculogenic mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

Notch signaling in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

VEGFR1 and PKCα signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic drug resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0190-9

Delta-like 4/Notch signaling and its therapeutic implications

21 January 2018

1 reference

12 December 2020

Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry.

1 reference

12 December 2020

[Melanoma cell lines as the basis for antitumor vaccine preparation]

1 reference

12 December 2020

Role of Notch and its oncogenic signaling crosstalk in breast cancer

1 reference

12 December 2020

Signalling pathways in vasculogenic mimicry

1 reference

12 December 2020

VEGFRs and Notch: a dynamic collaboration in vascular patterning

1 reference

12 December 2020

[Tumor angiogenesis: recent progress and remaining challenges].

1 reference

12 December 2020

10.1007/S10238-012-0190-9

Identifiers

DOI

1 reference

11 September 2017

1 reference